Koral Shah, Hematology/Oncology Fellow at City of Hope, shared a post on X:
”New kid on the block in RCC: Bispecific T-cell engager targeting ENPP3. Prelim phase I data shared by Sumanta K. Pal with thoughtful discussion. Well tolerated & early signal of anti-tumor activity.
Check out City of Hope posters on ENPP3, CD70, & GPR65 in RCC tonight!”
More posts featuring Sumanta K. Pal on OncoDaily.